Summary
Other Scenarios:
- BAX - GE
- BAX - JNJ
- GE - BEC
- JNJ - BEC
| Buyer: | Baxter International Inc. (BAX) | Last Price: | 53.45 | Market Cap.: | 33.15B |
|---|---|---|---|---|---|
| Target: | Beckman Coulter, Inc. (BEC) | Last Price: | 40.57 | Market Cap.: | 2.54B |
Lines of Business Summary:
- Baxter International Inc. (BAX) competes in 1 industry and 172 product/service groups
- Beckman Coulter, Inc. (BEC) competes in 1 industry and 169 product/service groups
- A combined entity will have 0% Product/Service Group overlap
- Baxter International Inc. (BAX) has 0 and Beckman Coulter, Inc. (BEC) has 1 suppliers that rely on a material % of their business. They share 0 in common.
Product Summary:
Overlap & Complementary Sectors
| Sector | Buyer | Target | # of Focused Companies |
|---|---|---|---|
Healthcare |
|
|
846 |
Biopharmaceuticals |
|
368 | |
|
Healthcare Services |
|
142 | |
|
Medical Devices |
|
|
225 |
|
Nutritional Health |
|
28 | |
|
Outsourced Services |
|
|
48 |
|
Scientific Products |
|
25 |
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Sample Products in Similar Lines of Business |
Sample Products in Complementary Lines of Business |
||
Buyer (Total: 220)
|
Target (Total: 294)
|
Buyer
|
Target
|
Business Relationship Summary:
Top Key Suppliers |
Top Key Customers |
||
Buyer (Total: 18)
|
Target (Total: 8)
|
Buyer (Total: 13)
|
Target (Total: 5)
|
Key Financial Summary:
Key Metrics
| Buyer | Target | |
|---|---|---|
| Number of Employees | 46,000 | 10,500 |
| Revenue Per Employee | 274,752.8 | 289,860.8 |
| Total Revenue | 3,151.0 | 758.8 |
| Total Expenses | 2,541.0 | 717.6 |
Other Revenue
|
0.0 | 0.0 |
|
Cost of Revenue
|
1,630.0 | 406.8 |
|
SG&A Expense
|
681.0 | 209.2 |
|
Research & Development
|
230.0 | 74.8 |
|
Other Operating Expense
|
0.0 | 0.0 |
|
Operating Income
|
610.0 | 41.2 |
|
Unusual Income
|
0.0 | 26.8 |
|
LT Debt to Capital
|
31.09 | 37.67 |
|
Fwd P/E
|
15.51 | 11.07 |
|
Fwd P/Rev
|
2.61 | 0.80 |
| Book Value | 7,059.0 | 1,534.6 |
|
Curr Portion of LTD/Cap Lease
|
5.0 | 4.2 |
Individual Company Summary
Focused
Buyer
Focused ():
Healthcare > Medical Devices
Target
Focused ():
Healthcare > Medical Devices > Clinical Diagnostics
Business Description
Buyer
Baxter International Inc. (Baxter) develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global diversified healthcare company, Baxter applies a combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and by patients at home under physician supervision. The Company operates in three segments: The BioScience, Medication Delivery and Renal.
Target
Beckman Coulter, Inc. is a manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Its products are used in a range of applications, from lab solutions used for pioneering medical research, clinical research and drug discovery to diagnostic systems found in hospitals and physicians? offices to aid in patient care. The Company markets its products in more than 130 countries. During the year ended December 31, 2007, approximately 48% of revenue of the Company came from outside the United States. The Company has four product areas: Chemistry Systems, Immunoassay Systems, Cellular Systems, and Discovery and Automation Systems. On December 28, 2007, the Company acquired the flow cytometry instrument business of Dako Denmark A/S.
Deal Summary
Key Ratios
| Buyer | Target | |
|---|---|---|
|
Gross Margin %
|
49.18 | 46.35 |
|
Operating Margin %
|
20.22 | 8.39 |
|
Quick Ratio
|
1.29 | 1.11 |
|
Current Ratio
|
2.24 | 2.2 |
|
Coverage Ratio
|
-0.03 | -0.13 |
| Total Assets | 15,209.0 | 3,616.8 |
| Return on Equity % | 27.24 | 10.53 |
| Return on Assets % | 12.64 | 4.47 |
|
Cash+ ST Inv. Per Share
|
3.43 | 1.11 |
| Total Debt | 3,420.0 | 998.7 |
| Total Debt to Equity % | 48.45 | 65.08 |
| Total Debt to Tangible Equity % | 63.94 | 229.43 |
|
Debt to Asset %
|
22.49 | 27.61 |
Product Summary
| Sector | Buyer | Target |
|---|---|---|
|
Healthcare |
|
|
Biopharmaceuticals |
|
|
|
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
|
|
|
|
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
|
|
|
|
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
|
|
|
|
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
|
|
|
|
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
|
|
|
|
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
|
|
|
|
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
|
|
|
|
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
|
|
|
|
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
|
|
|
|
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
|
|
|
|
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
|
|
|
|
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
|
|
|
|
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
|
|
|
|
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
|
|
|
|
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
|
|
|
|
Healthcare Services |
|
|
|
Patient Care
The Patient Care Subsector is comprised of companies that provide services to patients for the diagnosis, treatment, and/or prevention of diseases and injuries.
|
|
|
|
Medical Devices |
|
|
|
Anesthesiology
The Anesthesiology Subsector includes medical devices that deliver and monitor anesthetics.
|
|
|
|
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
|
|
|
|
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
|
|
|
|
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
|
|
|
|
Gastroenterology
The Gastroenterology Subsector includes medical devices that diagnosis and treat conditions affecting the stomach and intestinal tract.
|
|
|
|
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
|
|
|
|
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
|
|
|
|
Neurology
The Neurology Subsector includes medical devices that diagnose, monitor and treat neurological disorders.
|
|
|
|
Ophthalmology
The Ophthalmology Subsector includes medical devices that diagnose and treat eye disorders.
|
|
|
|
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
|
|
|
|
Respiratory
The Respiratory Subsector includes medical devices that diagnose and treat respiratory diseases.
|
|
|
|
Transfusion Medicine
The Transfusion Medicine Subsector includes medical devices and accessories that prepare or implement blood transfusion.
|
|
|
|
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
|
|
|
|
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
|
|
|
|
Nutritional Health |
|
|
|
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
|
|
|
|
Outsourced Services |
|
|
|
Bioanalytical Services
The Bioanalytical Services Subsector includes outsourced services that utilize bioanalytical instruments to analyze biological samples.
|
|
|
|
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
|
|
|
|
Drug Discovery Services
The Drug Discovery Services Subsector includes companies that provide biopharmaceutical companies with novel biological targets and drug leads.
|
|
|
|
Scientific Products |
|
|
|
Analytical Instruments
The Analytical Instruments Subsector includes scientific products that determine the quantitative and qualitative nature of biochemical samples.
|
|
|
|
Bioanalytical Instruments
The Bioanalytical Instruments Subsector includes scientific products, devices and apparatuses that determine the quantitative and qualitative nature of a biological samples.
|
|
|
|
Consumables
The Consumables Subsector includes chemicals, reagents, standards, media, and disposable labware that are normally depleted or worn out by continuous use.
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Product Details
| Sector | Buyer | Target |
|---|---|---|
|
Healthcare |
|
|
|
Biopharmaceuticals |
|
|
Allergies |
|
|
Dermatology |
|
|
|
Antihistamines
Products that inhibit inflammation by blocking the action of histamines on tissues.
Buyer Products:
|
|
|
|
Ophthalmology |
|
|
|
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.
Buyer Products:
|
|
|
|
Upper Respiratory |
|
|
|
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.
Buyer Products:
|
|
|
|
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.
Buyer Products:
|
|
|
|
Cardiovascular System |
|
|
|
Heart Disorders |
|
|
|
Angina |
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.
Buyer Products:
|
|
|
|
Arrhythmia |
|
|
|
Adenosine A1 Receptor Agonists
Therapeutics that treat abnormal rhythm of the heart beat by selectively stimulating the A1 adenosine receptor, slowing the speed of AV nodal conduction
Buyer Products:
|
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat abnormal rhythm of the heart beat by inhibiting the stimulation of beta adrenergic receptors of the heart muscle.
Buyer Products:
|
|
|
|
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.
Buyer Products:
|
|
|
|
Heart Failure (HF) |
|
|
|
Complications |
|
|
|
Edema |
|
|
|
Loop Diuretic Agents
Therapeutics that treat the excessive accumulation of fluids by increasing the excretion of sodium, potassium, chloride ions, and water in urine.
Buyer Products:
|
|
|
|
Myocardial Infarction (MI) |
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat irreversible damage to the heart muscle by blocking the beta adrenergic receptors of the heart muscle.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Vascular Disorders |
|
|
|
Deep Vein Thrombosis (DVT) |
|
|
|
Anticoagulating Agents (Anticoagulants) |
|
|
|
Thrombin Inhibitors
Therapeutics that prevent or treat clots in blood vessels by preventing blood clots from forming.
Buyer Products:
|
|
|
|
Hypertension |
|
|
|
Alpha Adrenergic Receptor Agonists
Therapeutics that treat high blood pressure by stimulating the alpha adrenergic receptors of the heart muscle.
Buyer Products:
|
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.
Buyer Products:
|
|
|
|
Hypovolemia |
|
|
|
Plasma Volumizers |
|
|
|
Albumin-Based
Therapeutics based on plasma proteins that treat a decrease in circulating fluid (plasma) in the body by increasing plasma volume.
Buyer Products:
|
|
|
|
Thromboembolism |
|
|
|
Anticoagulating Agents (Anticoagulants) |
|
|
|
Platelet Aggregation Inhibitors |
|
|
|
Phosphodiesterase Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing platelets from clumping together.
Buyer Products:
|
|
|
|
Thrombin Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing blood clots from forming.
Buyer Products:
|
|
|
|
Digestive System |
|
|
|
Gastrointestinal Tract Disorders |
|
|
|
Gastroesophageal Disorders |
|
|
|
Gastroesophageal Reflux Disease (GERD) |
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat Gastroesophageal Reflux Disease (GERD) by blocking dopamine receptor and stimulating gastrointestinal movement without stimulating secretions from the pancreas, stomach or gall bladder.
Buyer Products:
|
|
|
|
Nausea/Vomiting |
|
|
|
Serotonin Receptor Antagonists
Therapeutics that treat nausea and vomiting by blocking the serotonin receptors.
Buyer Products:
|
|
|
|
Endocrinology/Metabolism |
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Hematology |
|
|
|
Hemophilia |
|
|
|
Hemophilia A |
|
|
|
Clotting Agents
Therapeutics that aid in blood coagulation.
Buyer Products:
|
|
|
|
Hemophilia B |
|
|
|
Clotting Agents
Therapeutics that assist in blood coagulation.
Buyer Products:
|
|
|
|
Red Blood Cell (RBC) Disorders |
|
|
|
Anemia |
|
|
|
Recombinant Human Erythropoietins
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues by stimulating red blood cell production.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Serum Factor Disorders |
|
|
|
Hypoalbuminemia |
|
|
|
Albumin-Based
Therapeutics based on plasma proteins that treat low levels of serum albumin.
Buyer Products:
|
|
|
|
Immunology |
|
|
|
Autoimmune Disorders |
|
|
|
Arthritis |
|
|
|
Rheumatoid Arthritis (RA) |
|
|
|
Analgesics |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.
Buyer Products:
|
|
|
|
Idiopathic Thrombocytopenia Purpura (ITP) |
|
|
|
Immunoglobulins
Therapeutics that treat a decrease in platelets by neutralizing autoantibodies with therapeutic antibodies.
Buyer Products:
|
|
|
|
Kawasaki Syndrome |
|
|
|
Immunoglobulins
Therapeutics that treat Kawasaki Syndrome by neutralizing autoantibodies with therapeutic antibodies.
Buyer Products:
|
|
|
|
Immune Deficiency Disorders |
|
|
|
Primary Immunodeficiency Diseases |
|
|
|
Immunoglobulins
Therapeutics that treat primary immunodeficiency diseases by providing the body with therapeutic antibodies.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Infectious Diseases |
|
|
|
Bacterial |
|
|
|
Antibacterial Agents |
|
|
|
Broad Spectrum |
|
|
|
Antibiotics |
|
|
|
Aminoglycosides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.
Buyer Products:
|
|
|
|
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.
Buyer Products:
|
|
|
|
Penicillin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis during active multiplication.
Buyer Products:
|
|
|
|
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.
Buyer Products:
|
|
|
|
Tetracyclines
Therapeutics that treat a wide variety of infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.
Buyer Products:
|
|
|
|
Narrow Spectrum |
|
|
|
Respiratory System |
|
|
|
Bronchitis |
|
|
|
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.
Buyer Products:
|
|
|
|
Pneumonia |
|
|
|
Diaminopyrimidines/Sulfonamides
Therapeutics that treat inflammation of the lungs caused by bacterial infection by inhibiting folic acid synthesis and bacterial growth.
Buyer Products:
|
|
|
|
Tuberculosis |
|
|
|
Antitubercular Agents
Therapeutics that treat a bacterial infection of the lung by inhibiting bacterial and mycobacterial RNA synthesis.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Urinary Tract Infections (UTI) |
|
|
|
Antibacterial Agents (Antibiotics) |
|
|
|
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections of the urinary tract by inhibiting dihydrofolate reductase resulting in decreased bacterial nucleic acid/protein production.
Buyer Products:
|
|
|
|
Vaccines |
|
|
|
Bacterial |
|
|
|
Combination |
|
|
|
Diphtheria/Tetanus/Acellular Pertussis (DTaP)
Therapeutics that prevent or treat infectious disease by producing or artificially increasing immunity to pathogens that cause diphtheria, tetanus, and acellular pertussis.
Buyer Products:
|
|
|
|
Mycological (Fungal) |
|
|
|
Antifungal Agents |
|
|
|
Narrow Spectrum |
|
|
|
Dermatology |
|
|
|
Tinea Barbae |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of the bearded area by inhibiting the biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Tinea Capitis |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of the scalp by inhibiting biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Tinea Corporis (Ringworm) |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by inhibiting the biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Tinea Cruris (Jock Itch) |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of the groin and perineum by inhibiting the biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Tinea Pedis |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of the feet by inhibiting the biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Tinea Unquium |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of the nails by inhibiting the biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Tinea Versicolor |
|
|
|
Penicillin Derivatives
Therapeutics that treat fungal infections of skin exposed to the sun characterized by patches of depigmentation by inhibiting the biosynthesis of cell walls.
Buyer Products:
|
|
|
|
Nervous System |
|
|
|
Cryptococcal Meningitis |
|
|
|
Triazoles
Therapeutics that treat fungal infections of lining of the brain and the spinal cord by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Otolaryngology (Ear/Nose/Throat) |
|
|
|
Esophageal Candidiasis |
|
|
|
Triazoles
Therapeutics that treat fungal infections of the esophagus caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Oropharyngeal Candidiasis |
|
|
|
Azoles |
|
|
|
Triazoles
Therapeutics that treat fungal infections of the mouth and pahrynx caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Vaginal Candidiasis |
|
|
|
Azoles |
|
|
|
Triazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Viral |
|
|
|
DNA Viruses |
|
|
|
Herpesvirus |
|
|
|
Herpes Simplex Type 1 |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Buyer Products:
|
|
|
|
Herpes Simplex Type 2 |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Buyer Products:
|
|
|
|
Varicella Zoster |
|
|
|
Herpes Zoster (Shingles) |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause shingles in adults by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Buyer Products:
|
|
|
|
Varicella (Chickenpox) |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause chicken pox in children by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Buyer Products:
|
|
|
|
Musculoskeletal System |
|
|
|
Skeletal Disorders |
|
|
|
Joint Disorders |
|
|
|
Osteoarthritis (OA) |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.
Buyer Products:
|
|
|
|
Rheumatoid Arthritis (RA) |
|
|
|
Analgesics |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.
Buyer Products:
|
|
|
|
Neurology |
|
|
|
Neurological Disorders |
|
|
|
Alzheimer`s Disease |
|
|
|
Immunoglobulins
Therapeutics that treat and manage Alzheimer's disease by providing a therapeutic protein.
Buyer Products:
|
|
|
|
Epilepsy |
|
|
|
Status Epilepticus |
|
|
|
Sodium Channel Modulators
Therapeutics that treat Status Epilepticus by modulating the portal that allows sodium into the nerve cells.
Buyer Products:
|
|
|
|
Headaches |
|
|
|
Vascular (Migraine) |
|
|
|
Prophylactic Treatments |
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat Migraine by inhibiting stimulation of beta adrenergic receptors.
Buyer Products:
|
|
|
|
Neuromuscular Disorders |
|
|
|
Myasthenia Gravis (MG) |
|
|
|
Cholinesterase Inhibitors
Therapeutics that treat Myasthenia Gravis by maintaining the transmission of nerve impulses by inhibiting the enzyme that breaks down acetylcholine.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of nervous system and mental disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Psychiatric Disorders |
|
|
|
Anxiety |
|
|
|
Generalized Anxiety Disorder (GAD) |
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat anxiety by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.
Buyer Products:
|
|
|
|
Sleep Disorders |
|
|
|
Insomnia |
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.
Buyer Products:
|
|
|
|
Oncology |
|
|
|
Breast Cancer |
|
|
|
Localized |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage breast cancers by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Hematology |
|
|
|
Leukemia (White Blood Cell Cancer) |
|
|
|
Lymphoid |
|
|
|
Acute |
|
|
|
Lymphoblastic |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of immature lymphocytic cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Lymphocytic |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of lymphocytic cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Chronic |
|
|
|
Lymphocytic (CLL) |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage slowly progressing cancers of lymphocytic cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Immunoglobulins
Therapeutics that treat and manage slowly progressing cancers of lymphocytic cells by providing a therapeutic protein.
Buyer Products:
|
|
|
|
Myeloid |
|
|
|
Acute |
|
|
|
Monocytic |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of mononuclear cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Myelogenous (AML) |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage rapidly progressing cancers of myelogenous cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Chronic |
|
|
|
Granulocytic |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage slowly progressing cancers of myelocytic cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Lymphoma (Lymphatic Cancer) |
|
|
|
Cutaneous T-Cell (CTCL) |
|
|
|
Mycosis Fungoides |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage T-Cell lymphomas of the skin by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Hodgkin`s Disease |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage lymphoma characterized by the presence of Reed-Sternberg cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Non-Hodgkin`s Lymphoma (NHL) |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage lymphomas of B-cells and T-cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Multiple Myeloma (Plasma Cell Cancer) |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of mature antibody producing white blood cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Neurology |
|
|
|
Brain Cancer |
|
|
|
Neuroblastoma |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancer of primitive ganglion cells by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Opthalmology |
|
|
|
Retinoblastoma |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancers of the retina by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer and are currently in an early research or preclinical stage of development.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Ovarian Cancer |
|
|
|
Adenocarcinoma |
|
|
|
Alkylating Agents |
|
|
|
Nitrogen Mustard Type
Therapeutics derived from mustard gas that treat and manage cancer of cells lining the ovary by interacting with DNA and inhibiting cell division.
Buyer Products:
|
|
|
|
Pain Management |
|
|
|
Anesthesia |
|
|
|
General (Systemic) |
|
|
|
Adjunctive |
|
|
|
Acetylcholine Blocking Agents
Therapeutics that inhibit neuromuscular activity by competing with acetylcholine at the cholinergic receptors resulting in neuromuscular blockage.
Buyer Products:
|
|
|
|
Ether-Based Agents
Therapeutics that result in anesthesia due to interfering with the physiological functioning of nerve cell membranes in the brain.
Buyer Products:
|
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that result in anesthesia by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.
Buyer Products:
|
|
|
|
Hypnotic Agents (Sedatives)
Therapeutics that result in anesthesia by inducing sleep. These therapeutics have no analgesic action.
Buyer Products:
|
|
|
|
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters both the perception of pain as well as the emotional response to pain.
Buyer Products:
|
|
|
|
Reversal |
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Antagonists
Therapeutics that reverse general anesthesia by competitively inhibiting benzodiapizines at the GABA receptors, thus reducing their effect and reversing the anesthesia.
Buyer Products:
|
|
|
|
Narcotics |
|
|
|
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.
Buyer Products:
|
|
|
|
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.
Buyer Products:
|
|
|
|
Non-Narcotics |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.
Buyer Products:
|
|
|
|
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.
Buyer Products:
|
|
|
|
Respiratory System |
|
|
|
Lower Respiratory Tract Disorders (Lung Disorders) |
|
|
|
Bronchitis |
|
|
|
Complications |
|
|
|
Bacterial Infections |
|
|
|
Antibacterial Agents (Antibiotics) |
|
|
|
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.
Buyer Products:
|
|
|
|
Emphysema |
|
|
|
Congenital |
|
|
|
Proteinase Inhibitors
Therapeutics that treat emphysema by providing certain proteins. The body's lack of ability to manufacture these proteins results in the disease state.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of respiratory disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Upper Respiratory Tract Disorders |
|
|
|
Coughs/Colds |
|
|
|
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.
Buyer Products:
|
|
|
|
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and reduces the amount of mucous build up.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation, preventing congestion and altering both the perception and emotional response to pain.
Buyer Products:
|
|
|
|
Antihistamines/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation and altering both the perception and emotional response to pain.
Buyer Products:
|
|
|
|
Surgery |
|
|
|
Cardiovascular System |
|
|
|
Thrombosis |
|
|
|
Thrombin Inhibitors
Therapeutics that thin the blood of a blocked blood vessel during surgery by blocking an enzyme involved in the clotting process.
Buyer Products:
|
|
|
|
General |
|
|
|
Complications |
|
|
|
Hemorrhage |
|
|
|
Fibrinolysis Inhibitors
Therapeutics that treat complications involving bleeding after surgical procedures by inhibiting the breakdown of fibrin in blood clots.
Buyer Products:
|
|
|
|
Thrombosis |
|
|
|
Anticoagulating Agents (Anticoagulants) |
|
|
|
Thrombin Inhibitors
Therapeutics used to control and treat blood clots by preventing the action of thrombin, a key enzyme involved in the clot formation process.
Buyer Products:
|
|
|
|
Musculoskeletal System |
|
|
|
Deep Vein Thrombosis (DVT) |
|
|
|
Anticoagulating Agents (Anticoagulants) |
|
|
|
Thrombin Inhibitors
Therapeutics that treat vascular obstructions due to platelets and cell matter by blocking an enzyme involved in the clotting process.
Buyer Products:
|
|
|
|
Neurology |
|
|
|
Seizures |
|
|
|
Sodium Channel Modulators
Therapeutics that treat seizures by controlling the entrance of sodium into the nerve cells.
Buyer Products:
|
|
|
|
Toxicology |
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of toxicity in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Substance Abuse |
|
|
|
Withdrawal |
|
|
|
Alcohol |
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat alcohol withdrawal by increasing the effect of GABA at the relevant neuroreceptors.
Buyer Products:
|
|
|
|
Narcotics |
|
|
|
Opioid Antagonists
Therapeutics that treat narcotic addiction by blocking the effect of opioids.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Urological Disorders |
|
|
|
Bladder |
|
|
|
Cystitis |
|
|
|
Urotoxin Neutralizing Agents
Therapeutics that inhibit cystis induced by toxic therapeutics by neutralizing these therapeutics.
Buyer Products:
|
|
|
|
Healthcare Services |
|
|
|
Patient Care |
|
|
|
Ambulatory/Outpatient |
|
|
|
Specialized |
|
|
|
Dialysis
The process of cleansing the blood of end stage renal disease patients (ESRD) through the use of a semipermeable membrane, which allows waste products to pass but retains most of the blood's normal constituents. Dialysis services can be provided in outpatient settings, in patients' home, or in hospitals as a contractor.
Buyer Products:
|
|
|
|
Medical Devices |
|
|
|
Anesthesiology |
|
|
|
Diagnostic |
|
|
|
Monitoring |
|
|
|
Systems |
|
|
|
Consciousness Monitoring
Systems designed to monitor the effect of anesthesia on patients during surgery.
Buyer Products:
|
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Delivery Systems |
|
|
|
Gas |
|
|
|
Breathing Accessories
Ancillary devices used to aid the administering of inhaled anesthetics, such as breathing bags and breathing masks.
Buyer Products:
|
|
|
|
Breathing Circuits
Devices which assist in physical mechanism of breathing.
Buyer Products:
|
|
|
|
Percutaneous (Subcutaneous/Intramuscular/Intravenous) |
|
|
|
Fluid Administration Sets
Intravenous fluid administration sets used to deliver anesthesia.
Buyer Products:
|
|
|
|
Pumps/Systems
Devices used to pump intravenous fluids at a consistent programmed rate.
Buyer Products:
|
|
|
|
Viscoelastics
Materials that can be applied to the skin and decrease resistance of to injected drugs.
Buyer Products:
|
|
|
|
Procedure/Region Specific |
|
|
|
Delivery Systems |
|
|
|
Epidural
Devices used to inject anesthetic into the epidural space to numb the legs and abdomen, which include catheters, needles, syrninges and other prepackaged kits.
Buyer Products:
|
|
|
|
Nerve Block
Devices used to assist in the delivery of nerve block anesthetic, which include catheters, needles and other prepackaged kits.
Buyer Products:
|
|
|
|
Spinal
Devices used to inject anesthetic into the spine, which include catheters, needles and other prepackaged kits.
Buyer Products:
|
|
|
|
Cardiology |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Accessories |
|
|
|
Vessel Closure
Devices used to close heart blood vessels.
Buyer Products:
|
|
|
|
Clinical Diagnostics |
|
|
|
Chemistry |
|
|
|
Analyzers |
|
|
|
Accessories
Devices which may be used in conjunction with chemistry analyzers.
Target Products:
|
|
|
|
Automation/Robotics
Equipment used to automate processes in a clinical laboratory.
Target Products:
|
|
|
|
Blood Gas
Analyzers used to measure blood gases for diagnostic purposes.
Target Products:
|
|
|
|
Discrete |
|
|
|
Limited Assay
Discrete analyzers with limited test menu.
Target Products:
|
|
|
|
Multiple Assay
Multi-System analyzers designed for high throughput generally used in high volume clinical laboratories.
Target Products:
|
|
|
|
Protein |
|
|
|
Electrophoresis
Chemistry analyzers designed to qualitatively and quantitatively measure human protein in body fluids using a technique of electrochemical separation known as electrophoesis.
Target Products:
|
|
|
|
Point of Care Testing |
|
|
|
Critical Care Analysis |
|
|
|
Analyzers
Chemistry analyzers which may be used for the chemical analysis of body fluids and designed for use at the bedside during the course of patient care.
Target Products:
|
|
|
|
Test Cartridges
Specific analyte test devices used in conjunction with critical care chemistry analyzers.
Target Products:
|
|
|
|
Kits |
|
|
|
Blood Detection
Test kits which test for the presence of blood in body fluids or stool samples.
Target Products:
|
|
|
|
Cardiac
Test kits used to aid in the diagnosis of heart conditions.
Target Products:
|
|
|
|
Toxicology/Abuse Drugs
Test kits which test for the presence of drugs of abuse.
Target Products:
|
|
|
|
Reagents |
|
|
|
Calibrators |
|
|
|
Blood Gas
Calibrators used with blood gas analyzers.
Target Products:
|
|
|
|
Routine Analyte |
|
|
|
Multiple
Calibrators which contain multiple specific analytes used to establish the accuracy of chemistry analyzers.
Target Products:
|
|
|
|
Single
Calibrators which contain a specific analyte used to establish the accuracy of chemistry analyzers.
Target Products:
|
|
|
|
Controls |
|
|
|
Blood Gas
Controls used to verify the accuracy of blood gas test systems.
Target Products:
|
|
|
|
Test Kits |
|
|
|
Hemoglobin |
|
|
|
Glycohemoglobin
Test kits used to measure glycohemoglobin in human blood.
Target Products:
|
|
|
|
Photometric |
|
|
|
Cardiac |
|
|
|
HDL Cholesterol
High density lipoprotein cholesterol.
Target Products:
|
|
|
|
Enzymes
Photometric test kits which quantitatively measure for specific metabolic enzymes in body fluids.
Target Products:
|
|
|
|
Routine Metabolic Analytes
Photometric test kits which quantitatively measure for specific metabolic analyses in body fluids.
Target Products:
|
|
|
|
Proteins |
|
|
|
Apolipoproteins/Lipoproteins
Lipoproteins and apolipoproteins are useful in measuring risk of cardiac disease.
Target Products:
|
|
|
|
Electrophoresis Kits
Test kits to facilitate protein electrophoresis (fractionation).
Target Products:
|
|
|
|
Immunoglobulins
Tests designed to measure various types of Immunoglobulins.
Target Products:
|
|
|
|
Prealbumin/Albumin
Tests to measure prealbumin and/or albumin.
Target Products:
|
|
|
|
Hematology |
|
|
|
Analyzers |
|
|
|
Accessories
Disposables,consumables or peripheral equipment designed to augment or to be used in conjunction with hematology analyzers.
Target Products:
|
|
|
|
Flow Cytometers
Hematology analyzers designed to specifically differentiate and quantify leucocytes in human blood.
Target Products:
|
|
|
|
Multiple Parameter
Hematology analyzers designed for use in determining multiple hematological parameters in a clinical setting.
Target Products:
|
|
|
|
Reticulocyte/Erythrocyte
Hematology analyzers or devices designed to specifically differentiate and quantify reticulocytes or erythrocytes in human blood.
Target Products:
|
|
|
|
Reagents |
|
|
|
Analyzer Reagents
Reagents which are used with automated hematology analyzers.
Target Products:
|
|
|
|
Controls
Controls used to verify the function and test reliability of hematology analyzers.
Target Products:
|
|
|
|
Hemostasis/Coagulation |
|
|
|
Analyzers |
|
|
|
Automated
Automated coagulation analyzers.
Target Products:
|
|
|
|
Point Of Care Testing
Devices used to perform coagulation studies at the point of patient care. For example, at the bedside or doctor's office.
Target Products:
|
|
|
|
Reagents |
|
|
|
Controls
Control reagents used to verify the function and test reliability coagulation analyzers or assay systems.
Target Products:
|
|
|
|
Test Kits |
|
|
|
Activated Partial Thromboplastin Time
Reagents used to perform the Activated Partial Thromboplastin Time test.
Target Products:
|
|
|
|
Antithrombin-III
Test kits used to assay for antithrombin-III.
Target Products:
|
|
|
|
D-Dimer
Test kits used to assay for D-Dimer, a component of fibrin (clot) degradation..
Target Products:
|
|
|
|
Factor ID
Reagents used to perform coagulation factor assays.
Target Products:
|
|
|
|
Fibrinogen
Reagents used to perform fibrinogen assays.
Target Products:
|
|
|
|
Heparin
Test kits used to assay for heparin.
Target Products:
|
|
|
|
Protein-C
Test kits used to assay for Protein C.
Target Products:
|
|
|
|
Prothrombin Time
Reagents used to perform prothrombin time assays.
Target Products:
|
|
|
|
Specialty Assays
Test kits used to assay for special, esoteric coagulation factors..
Target Products:
|
|
|
|
Thrombin Time
Test kits used to perform the thrombin time test.
Target Products:
|
|
|
|
Immunoassays |
|
|
|
Analyzers |
|
|
|
Accessories
Reagents and equipment used to facilitate immunoassay testing.
Target Products:
|
|
|
|
Allergy
Analyzers used to perform allergy testing.
Target Products:
|
|
|
|
Autoimmune
Analyzers used to perform autoimmune testing.
Target Products:
|
|
|
|
Multiple Assay
Immunoassay analyzer designed to perform multiple assays over multiple modalities.
Target Products:
|
|
|
|
Therapeutic Drugs
Immunoassay analyzers designed to test for therapeutic drug levels.
Target Products:
|
|
|
|
Reagents |
|
|
|
Calibrators |
|
|
|
Immunoassay
Reagents with known values (standards) designed to adjust parameters on immunoassay instrumentation so as to maximize accuracy of the analysis.
Target Products:
|
|
|
|
Therapeutic Drugs
Calibrators used in the measurement of therapeutic drugs.
Target Products:
|
|
|
|
Toxicology/Abuse Drugs
Calibrators used in the measurement of drugs of abuse.
Target Products:
|
|
|
|
Controls |
|
|
|
Immunoassay
Controls used to verify the accuracy of immuassay test systems.
Target Products:
|
|
|
|
Test Kits |
|
|
|
Allergy |
|
|
|
Specific Allergen
Allergy test kits specific to a single allergen.
Target Products:
|
|
|
|
Total IgE
Immunoassay test kits which quantitatively measures total IgE antibody in plasma or serum.
Target Products:
|
|
|
|
Autoimmune |
|
|
|
Anti-DNA Double Stranded Antibody
Immunoassay test kits which quantitatively measures anti-double stranded DNA antibody in plasma or serum.
Target Products:
|
|
|
|
Complement System
Test kits used to assay various components of the complement system and related analytes.
Target Products:
|
|
|
|
Rheumatoid Factors (RF)
Immunoassay test kits which quantitatively measure rheumatoid arthritis antibodies in plasma or serum.
Target Products:
|
|
|
|
Bacterial |
|
|
|
Chlamydia
Immunoassay kits which test for current or previous infection caused by the Chlamydia organism.
Target Products:
|
|
|
|
Helicobacter Pylori
Immunoassay kits which test for current or previous infection caused by the helicobacter pylori bacteria.
Target Products:
|
|
|
|
Streptococcus Group A
Immunoassay kits which test for current infection caused by the Streptococcus A bacteria.
Target Products:
|
|
|
|
Parasitic |
|
|
|
Toxoplasma
Immunoassay kit which tests for current or previous infection caused by Toxoplasma.
Target Products:
|
|
|
|
Radioimmunoassays |
|
|
|
Androgen
Radioimmunoassay test kits which measure for androgen hormones in plasma or serum.
Target Products:
|
|
|
|
Cancer Marker
Radioimmunoassay test kits which measure for cancer markers in plasma or serum.
Target Products:
|
|
|
|
Endocrine
Radioimmunoassay test kits which measure for analytes or hormones associated with endocrine function in plasma or serum.
Target Products:
|
|
|
|
Fertility/Reproduction
Radioimmunoassay test kits which measure for analytes or hormones associated with fertility and or reproduction in plasma or serum.
Target Products:
|
|
|
|
Growth/Bone
Radioimmunoassay test kits which measure for analytes or hormones associated with growth hormone or bone metabolism in plasma or serum.
Target Products:
|
|
|
|
Thyroid
Radioimmunoassay test kits which measure for hormones or analytes associated with thyroid function in plasma or serum.
Target Products:
|
|
|
|
Special/Immuno Chemistry |
|
|
|
Anemia |
|
|
|
EPO
Immunoassay test kit which quantitatively measures EPO in plasma or serum.
Target Products:
|
|
|
|
Ferritin
Immunoassay test kit which quantitatively measures ferritin in plasma or serum.
Target Products:
|
|
|
|
Folate
Immunoassay test kit which quantitatively measures folate in plasma or serum.
Target Products:
|
|
|
|
Intrinsic Factor Ab
Immunoassay test kit which quantitatively measures intrinsic factor Ab in plasma or serum.
Target Products:
|
|
|
|
Transferrin
Immunoassay test kit which quantitatively measures transferrin in plasma or serum.
Target Products:
|
|
|
|
Vitamin B12
Immunoassay test kit which quantitatively measures ferritin in plasma or serum.
Target Products:
|
|
|
|
Cancer Marker |
|
|
|
Alpha Fetoprotein (AFP)
Immunoassay test kits which quantitatively measures for alpha feto protein in plasma or serum.
Target Products:
|
|
|
|
CA 125
Immunoassay test kits which quantitatively measures for CA 125, a tumor marker in plasma or serum.
Target Products:
|
|
|
|
CA 15-3
Immunoassay test kits which quantitatively measures for CA 15-3, a tumor marker, in plasma or serum.
Target Products:
|
|
|
|
CA 19-9
Immunoassay test kits which quantitatively measures for CA 19-9, a tumor markers in plasma or serum.
Target Products:
|
|
|
|
CEA
Immunoassay test kits which quantitatively measures for CEA, carcinoembryonic antigen, in plasma or serum.
Target Products:
|
|
|
|
PSA/Prostate Specific Protein
Immunoassay test kits which quantitatively measures for prostate specific antigen or prostate specific protein in plasma or serum.
Target Products:
|
|
|
|
Cardiac |
|
|
|
Myocardial Infarction/Heart Failure |
|
|
|
B-Type Natriuretic Peptide (BNP)
Immunoassay test kits which quantitatively measure B-type natriuretic peptide in plasma or serum.
Target Products:
|
|
|
|
CK-MB
Immunoassay test kits which quantitatively measure creatinine kinase-MB fraction in plasma or serum.
Target Products:
|
|
|
|
Myoglobin
Immunoassay test kits which quantitatively measure for myoglobin in plasma or serum.
Target Products:
|
|
|
|
Troponin
Immunoassay test kits which quantitatively measure for troponin in plasma or serum.
Target Products:
|
|
|
|
Endocrine |
|
|
|
Insulin
Immunoassay test kits which quantitatively measures iinsulin in plasma or serum.
Target Products:
|
|
|
|
Microalbumin
Immunoassay test kits which quantitatively measures microalbumin in plasma or serum.
Target Products:
|
|
|
|
Fertility/Reproduction |
|
|
|
Alpha Fetoprotein (AFP)
Test kits to measure maternal AFB in order to screen for fetal neural tube defects. May have other fetal screening tests included.
Target Products:
|
|
|
|
B-hCG
Immunoassay test kits which quantitatively measures beta hCG, human chorionic gonadotrophin, in plasma or serum.
Target Products:
|
|
|
|
DHEA-SO4
Immunoassay test kits which quantitatively measures DHEA sulfate in plasma or serum.
Target Products:
|
|
|
|
Estradiol
Immunoassay test kits which quantitatively measures estradiol in plasma or serum.
Target Products:
|
|
|
|
Estriol
Immunoassay test kits which quantitatively measures estriol in plasma or serum.
Target Products:
|
|
|
|
FSH
Immunoassay test kits which quantitatively measures FSH, follicle stimulating hormone, in plasma or serum.
Target Products:
|
|
|
|
Inhibin
Immunoassay test kits which quantitatively measure inhibin in plasma or serum.
Target Products:
|
|
|
|
Lutenizing Hormone
Immunoassay test kits which quantitatively measures LH, lutinizing hormone, in plasma or serum.
Target Products:
|
|
|
|
Pregnancy Tests |
|
|
|
Serum/Urine
Immunoassay test kits which determine pregnancy in serum or urine.
Target Products:
|
|
|
|
Progesterone
Immunoassay test kits which quantitatively measures progesterone in plasma or serum.
Target Products:
|
|
|
|
Prolactin
Immunoassay test kits which quantitatively measures prolactin in plasma or serum.
Target Products:
|
|
|
|
Testosterone
Immunoassay test kits which quantitatively measures testosterone in plasma or serum.
Target Products:
|
|
|
|
General Immunodiagnostics |
|
|
|
C Reactive Protein
Immunoassay test kits which test for non specific disease states by testing for C-reactive protein.
Target Products:
|
|
|
|
Cytokine
Immunoassay test kits which quantitatively measures cytokines in plasma or serum.
Target Products:
|
|
|
|
Growth/Bone |
|
|
|
Alkaline Phosphatase Activity
Immunoassay test kits which quantitatively measures alkaline phosphatase activity in plasma or serum.
Target Products:
|
|
|
|
Cortisol
Immunoassay test kits which quantitatively measures cortisol in plasma or serum.
Target Products:
|
|
|
|
Human Growth Hormone
Immunoassay test kits which quantitatively measures human growth hormone in plasma or serum.
Target Products:
|
|
|
|
Parathyroid Hormone
Immunoassay test kits which quantitatively measures parathyroid hormone in plasma or serum.
Target Products:
|
|
|
|
Therapeutic Drugs
Immunoassay test kits which quantitatively measure for therapeutic drugs in serum or urine using automated instrumentation..
Target Products:
|
|
|
|
Thyroid |
|
|
|
Free T3
Immunoassay test kits which quantitatively measure for free T3 hormone in plasma or serum.
Target Products:
|
|
|
|
Free T4
Immunoassay test kits which quantitatively measure for free thyoxine hormone in plasma or serum.
Target Products:
|
|
|
|
T3 Uptake
Test kits which determine the serums' ability to bind thyroid hormone (T3), a parameter directly linked to the ability to maintain normal thyroid hormone levels.
Target Products:
|
|
|
|
Thyroglobulin
Assays used to measure thyroglobulin levels, a hormone useful in diagnosis of thyroid cancer.
Target Products:
|
|
|
|
Thyroid Stimulating Hormone (TSH)
Kits or reagents designed to detect and quantitate the concentration of Thyroid Stimulating Hormone in human blood samples.
Target Products:
|
|
|
|
Total T4
Immunoassay test kits which quantitatively measure for total thyroxine in plasma or serum.
Target Products:
|
|
|
|
Toxicology/Abuse Drugs |
|
|
|
Single Drug Kit
Immunoassay test kits which measure for a specific drug of abuse in body fluids.
Target Products:
|
|
|
|
Viral |
|
|
|
Cytomegalovirus
Immunoassay kit which tests for the presence of infectious disease or previous infection caused by cytomegalovruses.
Target Products:
|
|
|
|
Hepatitis
Immunoassay kits which tests for current or previous infection caused by Hepatitis viruses.
Target Products:
|
|
|
|
Human Immunodeficiency Virus (HIV) |
|
|
|
Serum |
|
|
|
EIA
Immunoassay kit which tests for the presence of infectious disease caused by the Human Immunodeficiency Virus in serum or plasma using EIA methodologies.
Target Products:
|
|
|
|
Rubella
Immunoassay kit which tests for the presence of infectious disease caused by the mumps virus.
Target Products:
|
|
|
|
Specimen Collection |
|
|
|
Blood |
|
|
|
Arterial |
|
|
|
ABG Collection Kits
Collection devices used to collect arterial blood samples.
Target Products:
|
|
|
|
Drug Delivery |
|
|
|
Infusion Therapy |
|
|
|
Accessories |
|
|
|
Admixture Systems
Medical systems designed to combine multiple medications for delivery to the patients
Buyer Products:
|
|
|
|
Closed Blood Sampling Systems
Sampling systems which do not use needles to access infusion systems to obtain a blood sample.
Buyer Products:
|
|
|
|
Filtration Products
Device used to filter fluids for infusion.
Buyer Products:
|
|
|
|
Fluid Administration/Extension Sets
Filtered IV sets designed for infusion therapy.
Buyer Products:
|
|
|
|
Fluid Warmers
Medical devices used to maintain the warmth of the medical products prior to and during the infusion process.
Buyer Products:
|
|
|
|
Needleless Fluid Administration/Extension Sets
Valve systems designed to work without needles to prevent patient injuries.
Buyer Products:
|
|
|
|
Pump Sets
Pump sets designed specifically for infusion therapy.
Buyer Products:
|
|
|
|
Delivery Systems |
|
|
|
Elastomeric Infusors
Infusion delivery system designed for small-volume fluid transmission (home use).
Buyer Products:
|
|
|
|
Pumps |
|
|
|
Multiple Channel
Multiple channel pump designed to deliver more than one infusion therapy to patients.
Buyer Products:
|
|
|
|
Single Channel
Single channel pump designed to deliver only one infusion therapy to patients.
Buyer Products:
|
|
|
|
Syringe
Syringe used in place of a pump to deliver infusion therapy.
Buyer Products:
|
|
|
|
Integrated/Comprehensive Systems
Complete infusion systems that include pumps, monitoring devices and other accessories.
Buyer Products:
|
|
|
|
Vascular Access |
|
|
|
Peripheral Intravenous Catheters |
|
|
|
Infusion Sets
Complete infusion sets containing peripheral intravenous catheters.
Buyer Products:
|
|
|
|
Standard
Non-ported peripheral intravenous catheters.
Buyer Products:
|
|
|
|
Gastroenterology |
|
|
|
Treatment |
|
|
|
Stomach |
|
|
|
Tubes |
|
|
|
Feeding
A tube that carries food to the stomach.
Buyer Products:
|
|
|
|
General Surgery |
|
|
|
Invasive |
|
|
|
Surgical-Site Treatments |
|
|
|
Anti-Adhesives/Anti-Scarring |
|
|
|
Gels
Gel-based products applied during interventional procedures to prevent adhesion to medical devices or to prevent scarring of the surgical site
Buyer Products:
|
|
|
|
Sealants |
|
|
|
Adhesives
Glue based products used to seal tissue during surgical procedures
Buyer Products:
|
|
|
|
Hemostatic |
|
|
|
Delivery Systems
Medical devices designed to deliver hemostatic sealants to the surgical site
Buyer Products:
|
|
|
|
Sponges
Microfibrillar sponge used when conventional hemostasis procedures are not effective.
Buyer Products:
|
|
|
|
Topical
Topical mixture used when conventional hemostasis procedures are not effective.
Buyer Products:
|
|
|
|
Medical Supplies |
|
|
|
Diagnostic |
|
|
|
Clinical Examination |
|
|
|
Basic Examining Tools
Medical instruments used to examine and monitor basic physiological functions, such as reflex, blood pressure, heart rate, and pulmonary capacity. These instruments include stethoscopes, sphygmomanometers, percussion hammers and other similar items.
Buyer Products:
|
|
|
|
Safety and Sterilization |
|
|
|
Safety |
|
|
|
Waste Management
Products used to control and contain biohazardous materials, such as chemical waste, fluid waste, and solid waste. These products may include bags, containers, and other more advanced waste treatment systems.
Buyer Products:
|
|
|
|
Treatment |
|
|
|
Wound Management/First Aid |
|
|
|
Cleaning/Healing Devices
Devices used to clean and facilitate healing of wounds, such as bandages, dressings, cleansers, anti-infective ointments, sponges, cold compresses and other similar items.
Buyer Products:
|
|
|
|
Neurology |
|
|
|
Diagnostic |
|
|
|
Monitoring |
|
|
|
Monitors |
|
|
|
Electroencephalograph (EEG) |
|
|
|
Intraoperative
An electroencephalograph that is used during surgery.
Buyer Products:
|
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Surgical Sealants
A glue like material, made up of biomaterials, that is used to close up surgical incisions.
Buyer Products:
|
|
|
|
Ophthalmology |
|
|
|
Surgical |
|
|
|
Procedure/Region Specific |
|
|
|
Cataract |
|
|
|
Viscoelastics
Material that can be applied to decrease resistance between two parts of the eye and promote healing and repair of damaged eye tissue.
Buyer Products:
|
|
|
|
Orthopedics |
|
|
|
Surgical |
|
|
|
Procedure Specific |
|
|
|
Bone Loss Reconstruction |
|
|
|
General |
|
|
|
Bone Fillers
Devices used to fill the formed bone cavity with hardening material.
Buyer Products:
|
|
|
|
Respiratory |
|
|
|
Treatment |
|
|
|
Assisted Breathing |
|
|
|
Intubation |
|
|
|
Breathing Circuits
Instrument used to measure respiratory parameters such as pressure.
Buyer Products:
|
|
|
|
Transfusion Medicine |
|
|
|
Blood Collection |
|
|
|
Accessories |
|
|
|
Collection/Storage
Devices, usually polymer plastic bags used for collection and subsequent storage of blood and blood components. Specific additives may or may not be incorporated to prevent the collected blood from clotting.
Buyer Products:
|
|
|
|
Apheresis Systems |
|
|
|
Plasma
Systems which separate and collect the plasma component of human blood while returning other blood components to the donor.
Buyer Products:
|
|
|
|
Platelets
Systems which separate and collect the platelet cell component of human blood while returning other blood components to the donor.
Buyer Products:
|
|
|
|
Red Blood Cells
Systems which separate and collect the red cell component of human blood while returning other blood components to the donor.
Buyer Products:
|
|
|
|
Blood Washers
Instruments used to wash blood cells in preparation for usage; they are often used to prepare frozen red blood cells for transfusion.
Buyer Products:
|
|
|
|
Filtration Systems
Medical devices used to filter leukocytes from blood during the transfusion process.
Buyer Products:
|
|
|
|
Viral Inactivation |
|
|
|
Plasma
Medical devices and technology which destroy infectious agents such as viruses in donor plasma without damaging the integrity of the plasma proteins.
Buyer Products:
|
|
|
|
Platelets
Medical devices and technology which destroy infectious agents such as viruses in blood products (platelets) without damaging the integrity of the donor platelet cells.
Buyer Products:
|
|
|
|
Red Blood Cells
Medical devices and technology which destroy infectious agents such as viruses in donor blood without damaging the integrity of the donor red blood cells.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Minimally Invasive/Cystoscopy |
|
|
|
Irrigation Pumps/Systems
Surgical instruments that pump fluids to irrigate/moisten the surface of the urinary organs
Buyer Products:
|
|
|
|
Treatment |
|
|
|
Renal |
|
|
|
Hemodialysis |
|
|
|
Components |
|
|
|
Concentrates
Chemicals used in hemodialysis.
Buyer Products:
|
|
|
|
Dialysate Parameter Monitors
Medical products used to monitor parameters such as fluid pressure, concentration, pH etc. during dialysis procedures.
Buyer Products:
|
|
|
|
Filtration |
|
|
|
Dialyzers
The instrument or medium used to effect chemical dialysis which allows for the diffusion of waste products and excess water into a dialysate solution.
Buyer Products:
|
|
|
|
Hemofilters
Filters used to separate the blood from the waste components during dialysis
through a convection process by creating negative pressure to draw out solute particles without using a dialysate solution.
Buyer Products:
|
|
|
|
Systems
A complete set of devices that act as a kidney to remove waste from the circulatory system.
Buyer Products:
|
|
|
|
Peritoneal Dialysis |
|
|
|
Components |
|
|
|
Solutions
Chemical agents used in peritoneal dialysis.
Buyer Products:
|
|
|
|
Systems |
|
|
|
Automated Peritoneal Dialysis (APD)
Complete set of instruments and devices that cycle solution to and from the patient's peritoneum during sleep.
Buyer Products:
|
|
|
|
Continuous Ambulatory (CAPD)
Complete set of instruments and devices that perform peritoneal dialysis that can be moved around with the patient.
Buyer Products:
|
|
|
|
Vascular |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Accessories |
|
|
|
Introducers
Devices used to provide percutaneous introduction of catheters, interventional devices, and temporary pacing leads into the vasculature.
Buyer Products:
|
|
|
|
Vessel Closure
Devices used to close and repair vascular structures, including both complete systems and associated clamps, felts and pledgets.
Buyer Products:
|
|
|
|
Nutritional Health |
|
|
|
Dietary/Naturopathic Supplements |
|
|
|
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.
Buyer Products:
|
|
|
|
Outsourced Services |
|
|
|
Bioanalytical Services |
|
|
|
Nucleic Acid Purification
Bioanalytical services that purify nucleic acids.
Target Products:
|
|
|
|
Nucleic Acid Sequencing
Bioanalytical services that identify the location of each nucleotide in a nucleic acid sample.
Target Products:
|
|
|
|
Development/Manufacturing Services |
|
|
|
Contract Manufacturing Organizations (CMO) |
|
|
|
Pharmaceuticals |
|
|
|
Final Dosage Forms
Contract Manufacturing Organizations (CMO) that produce large quantities of drug products in final dosage forms ready to be sold to end users.
Buyer Products:
|
|
|
|
Drug Discovery Services |
|
|
|
Lead Discovery/Validation/Optimization |
|
|
|
Assay Development
Bioanalytical services that are used to develop biologically based tests for use in high throughput screening (HTS).
Target Products:
|
|
|
|
High Throughput Screening (HTS)
Bioanalytical services that allow for the biological testing of up to 10,000 compounds each day.
Target Products:
|
|
|
|
Scientific Products |
|
|
|
Analytical Instruments |
|
|
|
Analyzers |
|
|
|
Particle Size
Analyzers that are used to determine the size distribution of particles based on various physical properties.
Particle size analyzers utilize various technologies including: gas adsoprtion, laser diffraction, electrical sensing zone, light extinction, laser doppler velocimetry, photon correlation.
Target Products:
|
|
|
|
Radiation
Gamma counter/liquid scintillation counter analyzers used to monitor and detect the amount of radiation in the environment or on surfaces.
Target Products:
|
|
|
|
Automation/Processing Equipment |
|
|
|
Automation Equipment |
|
|
|
Robotic Instruments |
|
|
|
Robotic Arms
Mechanical arms used to transport samples from one location to another.
Target Products:
|
|
|
|
Workstations
Robotic instrument systems that transfer liquid and gas samples and also heat and cool samples.
Target Products:
|
|
|
|
Chromatography |
|
|
|
Liquid Chromatography (LC) |
|
|
|
Systems |
|
|
|
High Pressure Liquid Chromatography (HPLC)
High Pressure Liquid Chromatography (HPLC) systems which run with high flow rate and are generally used to quantitate and characterize compounds.
Target Products:
|
|
|
|
Electrochemistry |
|
|
|
Components |
|
|
|
Electrodes
Electrochemical probes used to measure the electric components of a sample.
Target Products:
|
|
|
|
Systems |
|
|
|
Meters |
|
|
|
Multiple Parameter
Multiple parameter meters used to monitor a combination of physical characteristics of a sample, such as conductvitiy, dissolved oxygen, biochemical oxygen demand, ion selective, pH, redox, temperature, or total dissolved solids.
Target Products:
|
|
|
|
Single Parameter |
|
|
|
pH
Electrochemical meters used to measure the concentration of hydrogen ions (pH) in solution.
Target Products:
|
|
|
|
Titrators
Electrochemical systems used to determine the concentration of an unknown sample by comparing it with the concentration of a known standard.
Target Products:
|
|
|
|
Microscopy |
|
|
|
Imaging |
|
|
|
Software
Computer programs specified for imaging systems used in the analysis of samples.
Target Products:
|
|
|
|
Systems |
|
|
|
Single Parameter |
|
|
|
Fluorescent
Imaging analysis systems that are used for the acquisition, processing, and analysis of high resolution fluorescent images.
Target Products:
|
|
|
|
Spectroscopy |
|
|
|
Software
Computer programs specified for spectroscopy systems used in the analysis of samples.
Target Products:
|
|
|
|
Spectrometers |
|
|
|
Molecular |
|
|
|
Ultra Violet/Visible (UV-VIS)
Absorption spectrometers that measures samples with wavelengths ranging from 200 nm to 1000 nm.
Target Products:
|
|
|
|
Bioanalytical Instruments |
|
|
|
Biomolecular |
|
|
|
Electrophoresis |
|
|
|
Capillary Electrophoresis |
|
|
|
Accessories
Supplementary products used to enhance the performance of a capillary electrophoresis (CE) system.
Target Products:
|
|
|
|
Components |
|
|
|
Detectors
Capillary electrophoresis (CE) components that measures the amount of a compound.
Target Products:
|
|
|
|
Systems
Capillary electrophoresis components assembled as a single unit.
Target Products:
|
|
|
|
Microarray Technology |
|
|
|
Systems
Microarray/biochip technology components assembled as a single unit.
Target Products:
|
|
|
|
Microplate Readers |
|
|
|
Accessories |
|
|
|
Washers
Microplate reader accessories used to clean the well plates before use.
Target Products:
|
|
|
|
Software
Computer programs specified for microplate reader systems used in the analysis of samples.
Target Products:
|
|
|
|
Systems |
|
|
|
Single Parameter |
|
|
|
Fluorescence
Microplate reader systems that uses fluorescent detectors.
Target Products:
|
|
|
|
Luminescence
Microplate reader systems that uses luminescent detectors.
Target Products:
|
|
|
|
Wavelength
Microplate reader systems that uses wavelength detectors.
Target Products:
|
|
|
|
Sequencers |
|
|
|
Automated |
|
|
|
Nucleic Acid
Automated gel electrophoresis or capillary electrophoresis sequencers used to analyze nucleic acid sample.
Target Products:
|
|
|
|
Synthesizers |
|
|
|
Deoxyribonucleic Acid (DNA)/Oligonucleotides
Synthesizer system used for the identification and synthesis of nucleic acid samples.
Target Products:
|
|
|
|
Cellular |
|
|
|
Cell Preparers |
|
|
|
Systems
Cell preparer components that are assembled as a single unit.
Target Products:
|
|
|
|
Flow Cytometers |
|
|
|
Software
Computer programs specified for flow cytometer systems used in the analysis of samples.
Target Products:
|
|
|
|
Systems
Flow cytometer components assembled as a single unit.
Target Products:
|
|
|
|
Consumables |
|
|
|
Analytical Chemistry |
|
|
|
Analyzers |
|
|
|
Particle Size |
|
|
|
Reagents
Chemicals used in the preparation and analysis of samples.
Target Products:
|
|
|
|
Standards
Chemicals used as a reference compound.
Target Products:
|
|
|
|
Radiation |
|
|
|
Standards
Chemicals used as a reference compound.
Target Products:
|
|
|
|
Chromatography |
|
|
|
Liquid Chromatography (LC) |
|
|
|
Columns
Liquid chromatography (LC) consumable that is composed of a tube or a cylinder in which chromatographic analysis takes place.
Target Products:
|
|
|
|
Reagents
Chemicals used in the preparation and analysis of samples in
liquid chromatography (LC).
Target Products:
|
|
|
|
Standards
Chemicals used as a reference compound in liquid chromatography (LC).
Target Products:
|
|
|
|
Electrochemistry |
|
|
|
pH Meters |
|
|
|
Buffers
Solutions, where the hydrogen ion concentration is fixed, used to standardize a pH meter.
Target Products:
|
|
|
|
Storage Solutions
pH meter consumables that are used to store a pH probe when not in use.
Target Products:
|
|
|
|
Bioanalytical Chemistry |
|
|
|
Cell Biology |
|
|
|
Flow Cytometry |
|
|
|
Kits
A collection of reagents, standards, and other consumables assembled for used in various biological analyses.
Target Products:
|
|
|
|
Reagents
Flow cytometry chemicals used in the preparation and analysis of samples.
Target Products:
|
|
|
|
Immunology |
|
|
|
Kits |
|
|
|
Enzyme-Linked Immunoabsorbent Assay (ELISA)
Kits used for the generalized analysis of serum samples for the detection of antibodies to infectious diseases.
Target Products:
|
|
|
|
Radioimmunoassay (RIA)
Kits used for the detection of radioactive biomolecules.
Target Products:
|
|
|
|
Molecular Biology |
|
|
|
Electrophoresis |
|
|
|
Capillary Electrophoresis (CE) |
|
|
|
Capillary Cassettes
A cartridge in which very small diameter grooves are placed for use in the analysis and separation of biomolecular samples.
Target Products:
|
|
|
|
Capillary Columns
A very small diameter column used for the separation of nucleic acid samples.
Target Products:
|
|
|
|
Microarray Technology |
|
|
|
Kits
Microarray/biochip technology consumables that are assembled together with other products for use in the analysis of various genetic samples.
Target Products:
|
|
|
|
Microfluidics Technology |
|
|
|
Microfluidic Chips
Microarray/biochip components that contains a proprietary semiconductor chip used to control all aspects of the microchip assays, the processing, analysis, and reporting.
Target Products:
|
|
|
|
Microplate Readers |
|
|
|
Kits
Molecular biology consumable kits used with microplate readers
Target Products:
|
|
|
|
Nucleic Acid Analysis |
|
|
|
Kits |
|
|
|
Nucleic Acid |
|
|
|
Extraction
Nucleic acid analysis kits that are used for the extraction of genetic samples from tissues or gels.
Target Products:
|
|
|
|
Purification
Nucleic acid analysis kits that are used for purification of genetic samples.
Target Products:
|
|
|
|
Sequencing
Nucleic acid analysis kits that are used for the sequencing of genetic samples.
Target Products:
|
|
|
|
Synthesis
Nucleic acid analysis kits that are used for the synthesis of genetic samples.
Target Products:
|
|
|
|
Polymerase Chain Reaction (PCR) |
|
|
|
Purification
Polymerase chain reaction (PCR) consumables used for the purification of genetic samples.
Target Products:
|
|
|
|
Reagents |
|
|
|
Probes
Nucleic acid analysis reagents labeled with a detectable molecule.
Target Products:
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Relationship Details
Key Competitors
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Overlap | |||||||||
Bayer AG (ADR)
|
|
n/a | 37,070.582 | 5.13 | 9.81 | 0.81 | 0.96 | n/a | |
|
AMDL, Inc.
|
|
n/a | 13.361 | n/a | n/a | 0.72 | n/a | 0.48 | |
| Buyer | |||||||||
|
Bayer AG (ADR)
|
|
n/a | 37,070.582 | 5.13 | 9.81 | 0.81 | 0.96 | n/a | |
|
Fresenius Medical Care AG & Co. (ADR)
|
|
n/a | 13,150.879 | 16.43 | 15.98 | 1.26 | 1.22 | n/a | |
| Target | |||||||||
|
General Electric Company
|
|
n/a | 187,350.925 | 9.19 | 9.09 | 1.01 | 0.98 | 7.00 | |
|
Johnson & Johnson
|
|
n/a | 161,563.099 | 12.81 | 12.40 | 2.50 | 2.41 | 9.41 | |
|
Roche Holding Ltd. (ADR)
|
|
n/a | 117,567.267 | 14.05 | 14.03 | 3.00 | 2.80 | 5.13 | |
|
Abbott Laboratories
|
|
n/a | 81,845.952 | 18.00 | 15.67 | 2.84 | 2.73 | 27.92 | |
|
Siemens AG (ADR)
|
|
n/a | 51,167.912 | 7.04 | 7.58 | 0.52 | 0.47 | 7.53 | |
|
Bayer AG (ADR)
|
|
n/a | 37,070.582 | 5.13 | 9.81 | 0.81 | 0.96 | n/a | |
|
Becton, Dickinson and Co.
|
|
n/a | 15,863.274 | 14.08 | 12.85 | 2.22 | 2.09 | 4.24 | |
|
Hitachi, Ltd. (ADR)
|
|
n/a | 15,040.213 | n/a | 31.90 | 0.13 | 0.13 | 0.88 | |
|
Thermo Fisher Scientific Inc.
|
|
n/a | 14,274.683 | 15.12 | 10.35 | 1.36 | 1.29 | n/a | |
|
Agilent Technologies Inc.
|
|
n/a | 6,041.000 | 8.72 | 8.98 | 1.05 | 1.07 | 3.59 | |
|
Waters Corporation
|
|
n/a | 3,977.680 | 12.35 | 12.07 | 2.50 | 2.44 | 17.73 | |
|
Illumina, Inc.
|
|
n/a | 2,560.145 | 146.45 | 33.20 | 4.88 | 4.42 | 4.46 | |
|
Techne Corporation
|
|
n/a | 2,467.297 | 22.62 | 21.31 | 9.18 | 8.49 | 5.37 | |
|
Life Technologies Corp.
|
|
n/a | 2,053.121 | 11.46 | 8.65 | 1.45 | 1.27 | 7.06 | |
|
Bio-Rad Laboratories, Inc.
|
|
n/a | 1,998.096 | 18.15 | 14.71 | 1.12 | 1.07 | 3.81 | |
|
Mindray Medical International Limited
|
|
n/a | 1,942.207 | 4.99 | 17.88 | 1.22 | 3.32 | 6.86 | |
|
PerkinElmer, Inc.
|
|
n/a | 1,913.338 | 12.90 | 11.03 | 0.94 | 0.92 | n/a | |
|
Inverness Medical Innovations, Inc.
|
|
n/a | 1,282.775 | n/a | 8.89 | 0.86 | 0.74 | n/a | |
|
Hill-Rom Holdings, Inc.
|
|
n/a | 1,260.180 | 10.88 | 12.68 | 0.84 | 0.73 | 2.37 | |
|
Sequenom, Inc.
|
|
n/a | 954.427 | n/a | -20.62 | 20.70 | 18.73 | 7.66 | |
|
Luminex Corporation
|
|
n/a | 881.946 | 72.84 | 306.43 | 9.02 | 8.43 | 6.61 | |
- Defined by the Company
- Defined by Others
Dependent Suppliers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
|
Teva Pharmaceutical Industries Ltd (ADR)
|
|
n/a | 35,300.160 | 18.65 | 14.95 | 3.26 | 3.08 | 7.89 | |
|
Medco Health Solutions Inc.
|
|
n/a | 19,895.919 | 19.20 | 16.41 | 0.40 | 0.37 | n/a | |
|
WPP PLC (ADR)
|
|
n/a | 12,139.489 | 16.69 | 6.13 | 1.24 | 0.31 | n/a | |
|
CA, Inc.
|
|
n/a | 8,323.684 | 12.95 | 9.98 | 1.90 | 1.80 | n/a | |
|
Computer Sciences Corporation
|
|
n/a | 4,367.255 | 4.68 | 6.80 | 0.25 | 0.24 | 7.76 | |
|
Ariba, Inc.
|
|
n/a | 779.199 | n/a | 35.55 | 2.38 | 1.87 | n/a | |
|
Nektar Therapeutics
|
|
n/a | 526.018 | n/a | -3.37 | 4.12 | 4.86 | 18.63 | |
|
CRA International, Inc.
|
|
n/a | 286.331 | 16.76 | 16.64 | 0.73 | 0.76 | 3.45 | |
|
Halozyme Therapeutics, Inc.
|
|
n/a | 244.331 | n/a | -5.23 | 34.70 | 25.91 | 7.91 | |
|
Dyax Corp.
|
|
n/a | 180.653 | n/a | -1.93 | 6.00 | 5.56 | n/a | |
|
CapLease, Inc.
|
|
n/a | 86.710 | n/a | 1.55 | 0.47 | 0.42 | 0.26 | |
|
Trailer Bridge, Inc.
|
|
n/a | 53.602 | n/a | 23.63 | 0.41 | 0.39 | n/a | |
|
HealthStream, Inc.
|
|
n/a | 47.896 | 11.16 | 19.09 | 0.96 | 0.87 | 10.31 | |
|
Angiotech Pharmaceuticals, Inc. (USA)
|
|
n/a | 13.620 | n/a | -0.50 | 0.05 | 0.05 | n/a | |
|
Minrad International, Inc.
|
|
n/a | 4.240 | n/a | n/a | 0.16 | n/a | n/a | |
|
MTM Technologies, Inc.
|
|
n/a | 0.678 | n/a | n/a | 0.00 | n/a | n/a | |
|
Intercytex
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Target | |||||||||
|
Cornerstone Therapeutics, Inc.
|
|
10.00% | 105.732 | n/a | -0.47 | 6.63 | 4.86 | n/a | |
|
Techne Corporation
|
|
n/a | 2,467.297 | 22.62 | 21.31 | 9.18 | 8.49 | 5.37 | |
|
Inverness Medical Innovations, Inc.
|
|
n/a | 1,282.775 | n/a | 8.89 | 0.86 | 0.74 | n/a | |
|
JDS Uniphase Corporation
|
|
n/a | 623.190 | n/a | 9.68 | 0.40 | 0.33 | 1.16 | |
|
II-VI, Inc.
|
|
n/a | 494.274 | 6.85 | 11.99 | 1.48 | 1.67 | 1.82 | |
|
Affymetrix, Inc.
|
|
n/a | 187.441 | 7.95 | -5.82 | 0.43 | 0.49 | 0.48 | |
|
Versant Corporation
|
|
n/a | 56.187 | 6.01 | n/a | 2.26 | n/a | 2.23 | |
|
Spectral Diagnostics, Inc (USA)
|
|
n/a | 5.909 | n/a | n/a | 2.59 | n/a | 2.44 | |
- Defined by the Company
- Defined by Others
Key Customers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
|
Biogen Idec Inc.
|
|
n/a | 12,910.062 | 16.63 | 11.71 | 3.29 | 2.97 | 5.42 | |
|
DaVita Inc.
|
|
n/a | 4,930.500 | 13.64 | 13.10 | 0.89 | 0.83 | n/a | |
|
United Therapeutics Corporation
|
|
n/a | 1,248.084 | 30.94 | 24.92 | 4.70 | 4.22 | 2.96 | |
|
Amylin Pharmaceuticals, Inc.
|
|
n/a | 1,147.729 | n/a | -3.79 | 1.34 | 1.21 | 2.58 | |
|
Cerus Corporation
|
|
n/a | 30.550 | n/a | -0.94 | 2.00 | 1.72 | 0.77 | |
|
Neurobiological Technologies, Inc.
|
|
n/a | 18.308 | n/a | -0.82 | 1.27 | n/a | 1.06 | |
|
Advanced Life Sciences Holdings, Inc.
|
|
n/a | 16.322 | n/a | -0.65 | 529.10 | n/a | n/a | |
|
Nuvelo, Inc.
|
|
n/a | 16.099 | n/a | -0.48 | 1.06 | 1.02 | 0.37 | |
|
Threshold Pharmaceuticals, Inc.
|
|
n/a | 6.086 | n/a | -0.22 | 4.23 | n/a | 0.24 | |
|
Novation, LLC
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
|
Government - United Kingdom
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
|
Government - United States
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
|
Government - Austria
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Target | |||||||||
|
Roche Holding Ltd. (ADR)
|
|
n/a | 117,567.267 | 14.05 | 14.03 | 3.00 | 2.80 | 5.13 | |
|
GlaxoSmithKline plc (ADR)
|
|
n/a | 93,034.381 | 13.42 | 9.91 | 2.68 | 2.21 | 80.31 | |
|
Sigma-Aldrich Corporation
|
|
n/a | 4,891.430 | 14.30 | 14.13 | 2.20 | 2.08 | 4.96 | |
|
Inverness Medical Innovations, Inc.
|
|
n/a | 1,282.775 | n/a | 8.89 | 0.86 | 0.74 | n/a | |
|
EXACT Sciences Corporation
|
|
n/a | 10.899 | n/a | n/a | -8.02 | n/a | n/a | |
- Defined by the Company
- Defined by Others
Key Partners
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Overlap | |||||||||
|
Cornerstone Therapeutics, Inc.
|
|
n/a | 105.732 | n/a | -0.47 | 6.63 | 4.86 | n/a | |
| Buyer | |||||||||
|
Teva Pharmaceutical Industries Ltd (ADR)
|
|
n/a | 35,300.160 | 18.65 | 14.95 | 3.26 | 3.08 | 7.89 | |
|
Medco Health Solutions Inc.
|
|
n/a | 19,895.919 | 19.20 | 16.41 | 0.40 | 0.37 | n/a | |
|
Biogen Idec Inc.
|
|
n/a | 12,910.062 | 16.63 | 11.71 | 3.29 | 2.97 | 5.42 | |
|
Cardinal Health, Inc.
|
|
n/a | 11,273.849 | 9.03 | 8.12 | 0.12 | 0.11 | 6.82 | |
|
DaVita Inc.
|
|
n/a | 4,930.500 | 13.64 | 13.10 | 0.89 | 0.83 | n/a | |
|
Computer Sciences Corporation
|
|
n/a | 4,367.255 | 4.68 | 6.80 | 0.25 | 0.24 | 7.76 | |
|
Haemonetics Corporation
|
|
n/a | 1,454.037 | 25.38 | 23.11 | 2.58 | 2.42 | 3.86 | |
|
United Therapeutics Corporation
|
|
n/a | 1,248.084 | 30.94 | 24.92 | 4.70 | 4.22 | 2.96 | |
|
Amylin Pharmaceuticals, Inc.
|
|
n/a | 1,147.729 | n/a | -3.79 | 1.34 | 1.21 | 2.58 | |
|
The Medicines Company
|
|
n/a | 716.236 | n/a | -214.33 | 2.19 | 1.92 | 2.56 | |
|
Nektar Therapeutics
|
|
n/a | 526.018 | n/a | -3.37 | 4.12 | 4.86 | 18.63 | |
|
Cangene Corporation
|
|
n/a | 306.765 | 12.35 | n/a | 2.20 | n/a | 1.85 | |
|
Halozyme Therapeutics, Inc.
|
|
n/a | 244.331 | n/a | -5.23 | 34.70 | 25.91 | 7.91 | |
| Target | |||||||||
|
Roche Holding Ltd. (ADR)
|
|
n/a | 117,567.267 | 14.05 | 14.03 | 3.00 | 2.80 | 5.13 | |
|
Sigma-Aldrich Corporation
|
|
n/a | 4,891.430 | 14.30 | 14.13 | 2.20 | 2.08 | 4.96 | |
|
Bio-Rad Laboratories, Inc.
|
|
n/a | 1,998.096 | 18.15 | 14.71 | 1.12 | 1.07 | 3.81 | |
|
Inverness Medical Innovations, Inc.
|
|
n/a | 1,282.775 | n/a | 8.89 | 0.86 | 0.74 | n/a | |
|
Martek Biosciences Corp.
|
|
n/a | 956.476 | 21.03 | 25.36 | 2.78 | 2.58 | 1.93 | |
|
Celera Corporation
|
|
n/a | 750.050 | n/a | 90.30 | 4.46 | 3.56 | 1.99 | |
|
GTx, Inc.
|
|
n/a | 576.405 | n/a | -10.29 | 46.31 | 33.16 | 14.27 | |
|
Affymetrix, Inc.
|
|
n/a | 187.441 | 7.95 | -5.82 | 0.43 | 0.49 | 0.48 | |
|
Cornerstone Therapeutics, Inc.
|
|
n/a | 105.732 | n/a | -0.47 | 6.63 | 4.86 | n/a | |
|
EXACT Sciences Corporation
|
|
n/a | 10.899 | n/a | n/a | -8.02 | n/a | n/a | |
|
The Johns Hopkins University
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Financials
| Buyer | Target | Combined Entity | |
|---|---|---|---|
| Income Statement | |||
| Operating Items | |||
| Revenue | 12,226.0 | 3,076.6 | 15,302.6 |
|
Other Revenue
|
0.0 | 0.0 | 0.0 |
| Total Revenue | 12,226.0 | 3,076.6 | 15,302.6 |
|
Cost of Revenue
|
6,213.0 | 1,650.7 | 7,863.7 |
|
SG&A Expense
|
2,678.0 | 818.7 | 3,496.7 |
|
Depreciation & Amortization
|
0.0 | 0.0 | 0.0 |
|
Research & Development
|
863.0 | 312.7 | 1,175.7 |
|
Interest Expense
|
0.0 | 0.0 | 0.0 |
|
Other Operating Expense
|
0.0 | 0.0 | 0.0 |
|
Unusual Expense (Income)
|
0.0 | 36.4 | 36.4 |
| Total Expenses | 9,754.0 | 2,818.5 | 12,572.5 |
|
Operating Income
|
2,472.0 | 258.1 | 2,730.1 |
| Non Operating Items | |||
|
Interest Expense (Inc.), Net Non-Oprtng
|
-74.0 | -33.0 | -107.0 |
|
Other, Net
|
-40.0 | -9.5 | -49.5 |
| Income Before Taxes | 2,358.0 | 215.6 | 2,573.6 |
| Income Taxes | 435.0 | 54.0 | 489.0 |
| Income After Taxes | 1,923.0 | 161.6 | 2,084.6 |
|
Net Income - Excl. Xord. Items
|
1,923.0 | 161.6 | 2,084.6 |
|
Net Income - Incl. Xord. Items
|
1,923.0 | 161.6 | 2,084.6 |
|
Income Avail. to Common
|
1,923.0 | 161.6 | 2,084.6 |
| Share Items | |||
|
Basic Avg. Shares Outstanding
|
625.0 | 62.8 | 687.8 |
|
Basic EPS - Excl. Xord. Items
|
3.08 | 2.57 | 3.03 |
|
Basic EPS - Incl. Xord. Items
|
3.08 | 2.57 | 3.03 |
| Full Dilution Adjustment | 0.0 | 0.0 | 0.0 |
| Fully Diluted Shares Outstanding | 638.0 | 64.3 | 702.3 |
|
F.D. EPS - Excl. Xord. Items
|
3.01 | 2.51 | 2.97 |
|
F.D. EPS - Incl. Xord. Items
|
3.01 | 2.51 | 2.97 |
| Dividends Per Common Share | 0.87 | 0.67 | 1.54 |
| Balance Sheet | |||
| Assets | |||
|
Cash and Equivalents
|
2,191.0 | 71.4 | 2,262.4 |
|
Accounts Receivable
|
2,101.0 | 696.8 | 2,797.8 |
|
Inventory
|
2,520.0 | 581.7 | 3,101.7 |
|
Other Current Assets
|
625.0 | 170.6 | 795.6 |
|
Current Assets
|
7,437.0 | 1,520.5 | 8,957.5 |
|
PPE
|
9,189.0 | 0.0 | 9,189.0 |
|
Accum D&A
|
-4,591.0 | 0.0 | -4,591.0 |
|
PPE, Net
|
4,598.0 | 892.9 | 5,490.9 |
| Goodwill & Intangibles | 1,710.0 | 1,099.3 | 2,809.3 |
| Other Assets | 0.0 | 0.0 | 0.0 |
|
Other LT Assets
|
1,054.0 | 104.1 | 1,158.1 |
| Total Assets | 15,209.0 | 3,616.8 | 18,825.8 |
| Liabilities | |||
| Accounts Payable | 0.0 | 204.0 | 204.0 |
| Payable/Accrued | 3,089.0 | 0.0 | 3,089.0 |
| Accrued Expenses | 0.0 | 415.4 | 415.4 |
|
ST Debt
|
230.0 | 66.9 | 296.9 |
|
Curr Port of LTD & Cap Lease Oblg
|
5.0 | 4.2 | 9.2 |
| Other (Current) Liabilities | 0.0 | 0.0 | 0.0 |
|
Current Liab.
|
3,324.0 | 690.5 | 4,014.5 |
|
LT Debt
|
3,185.0 | 927.6 | 4,112.6 |
|
Total LT Debt
|
3,185.0 | 927.6 | 4,112.6 |
| Deferred Taxes | 0.0 | 81.5 | 81.5 |
|
Other LT Liab.
|
1,641.0 | 382.6 | 2,023.6 |
|
Total Liabilities
|
8,150.0 | 2,082.2 | 10,232.2 |
| Shareholders Equity | |||
| Common Stock | 683.0 | 6.9 | 689.9 |
| Additional Paid in Capital | 5,418.0 | 551.1 | 5,969.1 |
| Retained Earnings | 5,415.0 | 1,331.2 | 6,746.2 |
| Treasure Stock | -3,491.0 | -358.1 | -3,849.1 |
| Other Equity | -966.0 | 3.5 | -962.5 |
|
Total Equity
|
7,059.0 | 1,534.6 | 8,593.6 |
|
Total Liab. & Equity
|
15,209.0 | 3,616.8 | 18,825.8 |
|
Shares Outstanding
|
622.8 | 62.6 | 685.4 |
| Cash Flow | |||
| Operating Cash Flow | |||
| CF Net Income | 1,923.0 | 161.6 | 2,084.6 |
| CF Depreciation | 634.0 | 247.1 | 881.1 |
| CF Deferred Taxes | 258.0 | -9.6 | 248.4 |
| Other Non-Cash Items | 300.0 | 68.5 | 368.5 |
| Change in Working Capital | -469.0 | -92.6 | -561.6 |
| Total Cash From Operating Activities | 2,646.0 | 375.0 | 3,021.0 |
| Investing Cash Flow (not calculated) | |||
| Capital Expenditures | -883.0 | -272.9 | -1,155.9 |
| Other Investing Cash Flows | -48.0 | -94.9 | -142.9 |
| Total Cash From Investing Activities | -931.0 | -367.8 | -1,298.8 |
| Financing Cash Flow (not calculated) | |||
| Dividends Paid | -517.0 | -42.3 | -559.3 |
| Purchase Or Sale of Stock | -1,689.0 | -46.5 | -1,735.5 |
| Purchase and Retirement of Debt | 141.0 | 68.6 | 209.6 |
| Other Financing Cash Flow | 639.0 | -0.5 | 638.5 |
| Total Cash From Financing Activities | -1,422.0 | -20.7 | -1,442.7 |
| Exchange Rate Effects | 80.0 | 0.1 | 80.1 |
| Net Change in Cash | 373.0 | -13.4 | 359.6 |
| Cash Taxes Paid | 304.0 | 98.0 | 402.0 |
| Cash Interest Paid | 119.0 | 45.5 | 164.5 |